Skip to main content

Peer Review reports

From: Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma

Original Submission
8 Oct 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Dec 2023 Reviewed Reviewer Report
2 Jan 2024 Reviewed Reviewer Report - Anik Karan
29 Jan 2024 Author responded Author comments - Qun Liang
Resubmission - Version 3
29 Jan 2024 Submitted Manuscript version 3
5 Mar 2024 Reviewed Reviewer Report
26 Mar 2024 Author responded Author comments - Qun Liang
Resubmission - Version 4
26 Mar 2024 Submitted Manuscript version 4
12 Apr 2024 Author responded Author comments - Qun Liang
Resubmission - Version 5
12 Apr 2024 Submitted Manuscript version 5
24 Apr 2024 Author responded Author comments - Qun Liang
Resubmission - Version 6
24 Apr 2024 Submitted Manuscript version 6
6 May 2024 Author responded Author comments - Qun Liang
Resubmission - Version 7
6 May 2024 Submitted Manuscript version 7
Publishing
7 May 2024 Editorially accepted
21 May 2024 Article published 10.1186/s12885-024-12356-w

You can find further information about peer review here.

Back to article page